Literature DB >> 16513113

Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.

Noraida C Zerpa1, Albina Wide, Jose Noda, Henry Bermúdez, Rosalba Pabón, Oscar O Noya.   

Abstract

To obtain antibodies suitable to be used in an antigen-capture assay, we have identified, synthesized, and evaluated a series of peptides from different Plasmodium falciparum excretory-secretory proteins: glutamate-rich protein (GLURP); histidine-rich protein 2; histidine-rich protein 3; Falciparum interspersed repeat antigen and, serine-rich antigen homologous. Conformational as well as antigenic predictions were performed using the ANTHEPROT package. Chemical synthesis was carried out by the multiple manual synthesis using the t-boc strategy. The peptides were used as antigens for the preparation of polyclonal antibodies in rabbits. Out of the 14 peptide constructs, eight by ELISA and, six by MABA elicited antibodies that showed correspondence between the predictive study and the immunogenicity obtained in rabbits. All antipeptide (GLURP, HRP2, and FIRA) antisera were found to bind to the corresponding synthetic sequence in an ELISA assay. The binding activity and specificity of antibodies were determined by Western blot with supernatant culture from P. falciparum. Anti-GLURP (IMT-94 and IMT-200) antisera bound to five molecules present in supernatant with molecular weight of 73, 82, 116, 124, and 128 kDa. Anti-HRP2 (IMT-192) antisera recognized a band of 58 kDa. In both cases, the specific molecules were inhibited by preincubation with the homologous peptide. Anti-HRP3, anti-FIRA neither anti-SERPH antisera showed reactivity. Anti-peptides HRP2 antibodies recognized the recombinant protein present in Parasight-F test. The same way, synthetic peptides from HRPII molecule were recognized by monoclonal antibody present in the Parasight-F assay. Our results confirm the potential value of synthetic peptides when inducing monospecific polyclonal antibodies for the development of diagnostic tests based on the capture of antigens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513113     DOI: 10.1016/j.exppara.2006.01.007

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

1.  Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2.

Authors:  Elisabeth Ravaoarisoa; Halima Zamanka; Thierry Fusai; Jacques Bellalou; Hugues Bedouelle; Odile Mercereau-Puijalon; Thierry Fandeur
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria.

Authors:  Albin Fontaine; Matthieu Pophillat; Stéphanie Bourdon; Claude Villard; Maya Belghazi; Patrick Fourquet; Claude Durand; Didier Lefranc; Christophe Rogier; Thierry Fusai; Lionel Almeras
Journal:  Malar J       Date:  2010-10-11       Impact factor: 2.979

3.  Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays.

Authors:  Jean Biram Sarr; Eve Orlandi-Pradines; Sonia Fortin; Cheikh Sow; Sylvie Cornelie; François Rogerie; Soihibou Guindo; Lassana Konate; Thierry Fusaï; Gilles Riveau; Christophe Rogier; Franck Remoue
Journal:  Parasit Vectors       Date:  2011-11-07       Impact factor: 3.876

4.  Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria.

Authors:  Mark Kaddumukasa; Catherine Lwanira; Allan Lugaajju; Elly Katabira; Kristina E M Persson; Mats Wahlgren; Fred Kironde
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

5.  A Dual, Systematic Approach to Malaria Diagnostic Biomarker Discovery.

Authors:  Seda Yerlikaya; Ewurama D A Owusu; Augustina Frimpong; Robert Kirk DeLisle; Xavier C Ding
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

6.  Initial characterization of Pf62, a novel protein of Plasmodium falciparum identified by immunoscreening.

Authors:  Eva M Moyano; Luis Miguel González; Estrella Montero; Laureano Cuevas; Esperanza Perez-Pastrana; Ysmael Santa-Maria; Agustín Benito
Journal:  Parasitol Res       Date:  2009-01-27       Impact factor: 2.289

7.  Cysticercus cellulosae antigens in the serodiagnosis of neurocysticercosis.

Authors:  Subhash Chandra Parija; Ar Gireesh
Journal:  Trop Parasitol       Date:  2011-07

8.  Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2.

Authors:  Chiuan Herng Leow; Martina Jones; Qin Cheng; Stephen Mahler; James McCarthy
Journal:  Malar J       Date:  2014-07-18       Impact factor: 2.979

9.  Stage-specific Plasmodium falciparum immune responses in afebrile adults and children living in the Greater Accra Region of Ghana.

Authors:  Festus K Acquah; Aminata C Lo; Kwadwo Akyea-Mensah; Hamza B Abagna; Babacar Faye; Michael Theisen; Ben A Gyan; Linda E Amoah
Journal:  Malar J       Date:  2020-02-10       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.